Howe & Rusling’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-210
Closed 377
2022
Q3
$0 Buy
210
+85
+68% +$175 ﹤0.01% 1056
2022
Q2
$0 Hold
125
﹤0.01% 1055
2022
Q1
$0 Sell
125
-36
-22% -$196 ﹤0.01% 1003
2021
Q4
$1K Buy
161
+34
+27% +$247 ﹤0.01% 908
2021
Q3
$1K Buy
127
+35
+38% +$339 ﹤0.01% 899
2021
Q2
$1K Buy
+92
New +$1.09K ﹤0.01% 860

Other funds holding AVAH

Howe & Rusling's AVAH Position: Q4 2022 in Review

Howe & Rusling sold out of Aveanna Healthcare (AVAH) in Q4 2022, closing a stake of 210 shares.

Howe & Rusling first reported a position in AVAH in Q2 2021 and held it in 6 quarters. The position peaked at $1K in Q4 2021. 81 funds tracked by Wall St. Rank hold AVAH as of Q4 2022.

  • Howe & Rusling reported no remaining Aveanna Healthcare position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 210 Aveanna Healthcare shares in Q4 2022.
  • Howe & Rusling first reported a position in Aveanna Healthcare in Q2 2021 and held it in 6 quarters.
  • Howe & Rusling's Aveanna Healthcare position peaked at $1K in Q4 2021.
  • 81 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.